Rajput, AH. Early onset parkinsonism. Adv Clin Neurosci. 1996;6:27-35.
Rajput, AH. Frequency and cause of Parkinson's disease. Can J Neurol Sci. 1992;19:103-107.
de Lau, LM, Breteler, MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006;5:525-535.
Quinn, N, Critchley, P, Marsden, C. Young onset Parkinson's disease. Mov Disord. 1987;2:73-91.
Schrag, A, Schott, JM. Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism. Lancet Neurol. 2006;5:355-363.
Giovannini, P, Piccolo, I, Genitrini, S, et al. Early-onset Parkinson's disease. Mov Disord. 1991;6:36-42.
Gershanik, OS. Early onset parkinsonism. Front Biosci. 2003;8:s568-s578.
Gomez Arevalo, G, Jorge, R, Garcia, S, Scipioni, O, Gershanik, O. Clinical and pharmacological differences in early- versus late-onset Parkinson's disease. Mov Disord. 1997;12:277-284.
Golbe, L. Young-onset Parkinson's disease: a clinical review. Neurology. 1991;41:168-173.
Gibb, WRG, Lees, AJ. A comparison of clinical and pathological features of young- and old-onset Parkinson's disease. Neurology. 1988;38:1402-1406.
Bostantjopoulou, S, Logothetis, J, Katsarou, Z, Mentenopoulos, G. Clinical observations in early and late onset Parkinson's disease. Funct Neurol. 1991;6:145-149.
Friedman, A. Old-onset Parkinson's disease compared with young-onset disease: clinical differences and similarities. Acta Neurol Scand. 1994;89:258-261.
Wickremaratchi, MM, Ben-Shlomo, Y, Morris, HR. The effect of onset age on the clinical features of Parkinson's disease. Eur J Neurol. 2009;16:450-456.
Schrag, A, Ben-Shlomo, Y, Quinn, N. Cross sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in London. BMJ. 2000;321:21-22.
Selikhova, M, Williams, DR, Kempster, PA, Holton, JL, Revesz, T, Lees, AJ. A Clinico-pathological study of subtypes in Parkinson's disease. Brain. 2009;132:2947-2957.
Pantelatos, A, Fornadi, F. Clinical features and medical treatment of Parkinson's disease in patient groups selected in accordance with age at onset. Adv Neurol. 1993;60:690-697.
Rajput, AH, Rozdilsky, B, Rajput, A, Ang, L. Levodopa efficacy and pathological basis of Parkinson syndrome. Clin Neuropharmacol. 1990;13(6):553-558.
Kempster, PA, Williams, DR, Selikhova, M, Holton, J, Revesz, T, Lees, AJ. Patterns of levodopa response in Parkinson's disease: A clinico-pathological study. Brain. 2007;130:2123-2128.
Rajput, AH, Fenton, ME, Birdi, S, et al. Clinical-pathological study of levodopa complications. Mov Disord. 2002;17:289-296.
Kostic, V, Przedborski, S, Flaster, E, Sternic, N. Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease. Neurology. 1991;41:202-205.
Hughes, AJ, Daniel, SE, Kilford, L, Lees, AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181-184.
Rajput, AH, Rozdilsky, B, Rajput, A. Accuracy of clinical diagnosis in Parkinsonism - A prospective study. Can J Neurol Sci. 1991;18:275-278.
Hoehn, MM, Yahr, MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427-442.
Jankovic, J, Kapadia, AS. Functional decline in Parkinson disease. Arch Neurol. 2001;58:1611-1615.
Rajput, AH, Stern, W, Laverty, WH. Chronic low-dose levodopa therapy in Parkinson's disease: an argument for delaying levodopa therapy. Neurology. 1984;34:991-996.
Markham, CH, Diamond, SG. Evidence to support early levodopa therapy in Parkinson's disease. Neurology. 1981;31:121-131.
Webster, DD. Critical analysis of the disability in Parkinson's disease. Mod Treat. 1968;5:257-282.
Fahn, S, Elton, RL, UPDRSDevelopmentCommittee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, editors. Recent Developments in Parkinson's Disease. Florham Park, NJ: MacMillan Healthcare Information; 1987:153-305.
Rajput, AH, Uitti, RJ, Offord, KP. Timely levodopa (LD) administration prolongs survival in Parkinson's disease. Parkinsonism Relat Disord. 1997;3:159-165.
Goetz, CG, Poewe, W, Rascol, O, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord. 2004;19:1020-1028.
Rajput, AH, Voll, A, Rajput, ML, Robinson, CA, Rajput, A. Course in Parkinson disease subtypes: A 39-year clinicopathologic study. Neurology. 2009;73:206-212.
Jellinger, K. The pathology of Parkinsonism. In: Marsden CD, Fahn S editors. Movement Disorders 2. London: Butterworth and Co,; 1987:124-165.
Gelb, DJ, Oliver, E, Gilman, S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999;56:33-39.
Duvoisin, R, Goble, LI. Toward a definition of Parkinson's disease. Neurology. 1989;39:746.
Gustavsson, EK, Trinh, J, Guella, I, et al. DNAJC13 genetic variants in parkinsonism. Mov Disord. 2015;30:273-278.
Dickson, DW, Braak, H, Duda, JE, et al. Neuropathological assessment of Parkinson's disease: Refining the diagnostic criteria. Lancet Neurol. 2009;8:1150-1157.
Foltynie, T, Brayne, C, Barker, RA. The heterogeneity of idiopathic Parkinson's disease. J Neurol. 2002;249:138-145.
Schrag, A, Ben-Shlomo, Y, Brown, R, Marsden, CD, Quinn, N. Young-onset Parkinson's disease revisited--clinical features, natural history, and mortality. Mov Disord. 1998;13:885-894.
Lewis, SJG, Foltynie, T, Blackwell, AD, Robbins, TW, Owen, AM, Barker, RA. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry. 2005;76:343-348.
Marder, K, Levy, G, Louis, ED, et al. Familial aggregation of early- and late-onset Parkinson's disease. Ann Neurol. 2003;54:507-513.
Ferguson, LW, Rajput, ML, Muhajarine, N, Shah, SM, Rajput, A. Clinical features at first visit and rapid disease progression in Parkinson's disease. Parkinsonism Relat Disord. 2008;14:431-435.
Liu, P, Feng, T, Wang, YJ, Zhang, X, Chen, B. Clinical heterogeneity in patients with early-stage Parkinson's disease: a cluster analysis. J Zhejiang Univ Sci B. 2011;12:694-703.
Schrag, A, Quinn, NP, Ben-Shlomo, Y. Heterogeneity of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2006;77:275-276.
Dauer, W, Przedborski, S. Parkinson's disease: mechanisms and models. Neuron. 2003;39:889-909.
Hindle, JV. Ageing, neurodegeneration and Parkinson's disease. Age Ageing. 2010;39:156-161.
Rajput, A, Uitti, RJ, Lang, AE, Rajput, AH. Amantadine (Amd) ameliorates levodopa (LD) induced dyskinesias (DK). Neurology. 1997;48:A328.
Uitti, RJ, Rajput, AH, Ahlskog, JE, et al. Amantadine treatment is an independent predictor of improved survival in Parkinson's disease. Neurology. 1996;46:1551-1556.
Spica, V, Pekmezovic, T, Svetel, M, Kostic, VS. Prevalence of non-motor symptoms in young-onset versus late-onset Parkinson's disease. J Neurol. 2013;260:131-137.
Reijnders, JS, Ehrt, U, Lousberg, R, Aarsland, D, Leentjens, AF. The association between motor subtypes and psychopathology in Parkinson's disease. Parkinsonism Relat Disord. 2009;15:379-382.
Jankovic, J. Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations. Mov Disord. 2005;20 (Suppl 11):S11-S16.
Ku, S, Glass, GA. Age of Parkinson's disease onset as a predictor for the development of dyskinesia. Mov Disord. 2010;25:1177-1182.
Kumar, N, Van Gerpen, JA, Bower, JH, Ahlskog, JE. Levodopa-dyskinesia incidence by age of Parkinson's disease onset. Mov Disord. 2005;20(3):342-344.
Sato, K, Hatano, T, Yamashiro, K, et al. Prognosis of Parkinson's disease: Time to Stage III, IV, V and to motor fluctuations. Mov Disord. 2006;21:1384-1395.
Alves, G, Wentzel-Larsen, T, Aarsland, D, Larsen, JP. Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology. 2005;65:1436-1441.
Hely, MA, Morris, JG, Traficante, R, Reid, WG, O'Sullivan, DJ, Williamson, PM. The Sydney multicentre study of Parkinson's disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry. 1999;67:300-307.
Kostic, VS, Marinkovic, J, Svetel, M, Stefanova, E, Przedborski, S. The effect of stage of Parkinson's disease at the onset of levodopa therapy on development of motor complications. Eur J Neurol. 2002;9:9-14.
Muller, J, Wenning, GK, Jellinger, K, McKee, A, Poewe, W, Litvan, I. Progression of Hoehn and Yahr stages in Parkinsonian disorders: a clinicopathologic study. Neurology. 2000;55:888-891.